Literature DB >> 14713391

Limitations of faecal elastase-1 and chymotrypsin as tests of exocrine pancreatic disease in adults.

W G Brydon1, K Kingstone, S Ghosh.   

Abstract

BACKGROUND: The faecal enzymes elastase and chymotrypsin are a relatively inexpensive non-invasive means of investigating causes of malabsorption. However, such tests may be affected by enzyme degradation or faecal dilution.
METHODS: Faecal elastase-1 and chymotrypsin were measured in 225 patients in whom pancreatic disease was suspected, and the association between faecal free water and pH with these faecal enzymes was examined in subjects with normal pancreatic function.
RESULTS: The sensitivity of faecal elastase-1 and chymotrypsin for identifying exocrine pancreatic disease was 75% and 60%, respectively. Corresponding specificities for excluding disease were 95% and 97%. The positive predictive value for faecal elastase-1 increased from 58% to 92% when watery diarrhoea was excluded. Faecal elastase-1 (inversely) and chymotrypsin (directly) were significantly associated with percentage faecal free water content in subjects without pancreatic disease. Faecal elastase-1 was not related to faecal pH, whereas chymotrypsin was inversely related to pH.
CONCLUSION: Faecal elastase-1 is a more sensitive test for exocrine pancreatic disease in adults but is affected by dilution in patients with watery diarrhoea. The value of faecal chymotrypsin is limited by intestinal degradation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14713391     DOI: 10.1258/000456304322664753

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  10 in total

1.  Chronic pancreatitis: diagnosis and management of complications.

Authors:  N I Church; S P Pereira; D Churchill; S Cairns; A R W Hatfield; G J M Webster
Journal:  Gut       Date:  2007-09       Impact factor: 23.059

2.  Pancreatic exocrine function is preserved after distal pancreatectomy.

Authors:  James E Speicher; L William Traverso
Journal:  J Gastrointest Surg       Date:  2010-04-13       Impact factor: 3.452

3.  Quantitative MRCP assessment of pancreatic exocrine reserve and its correlation with faecal elastase-1 in patients with chronic pancreatitis.

Authors:  R Manfredi; S Perandini; W Mantovani; L Frulloni; N Faccioli; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2012-01-07       Impact factor: 3.469

Review 4.  Pancreatic involvement in celiac disease.

Authors:  Daniel Vasile Balaban; Iulia Enache; Marina Ciochina; Alina Popp; Mariana Jinga
Journal:  World J Gastroenterol       Date:  2022-06-28       Impact factor: 5.374

5.  Using faecal elastase-1 to screen for chronic pancreatitis in patients admitted with acute pancreatitis.

Authors:  R C Turner; R McDermott
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

6.  Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology.

Authors:  A R Gillams; W R Lees
Journal:  Eur Radiol       Date:  2007-07-10       Impact factor: 5.315

7.  Prevalence of pancreatic insufficiency in inflammatory bowel diseases. Assessment by fecal elastase-1.

Authors:  Giovanni Maconi; Roberto Dominici; Mirko Molteni; Sandro Ardizzone; Matteo Bosani; Elisa Ferrara; Silvano Gallus; Mauro Panteghini; Gabriele Bianchi Porro
Journal:  Dig Dis Sci       Date:  2007-05-26       Impact factor: 3.199

Review 8.  Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician.

Authors:  Mohamed O Othman; Diala Harb; Jodie A Barkin
Journal:  Int J Clin Pract       Date:  2018-02-05       Impact factor: 2.503

9.  Exocrine Pancreatic Insufficiency Following Gastric Resectional Surgery-is Routine Pancreatic Enzyme Replacement Therapy Necessary?

Authors:  Rajeevan Philip Sridhar; Myla Yacob; Sudipta Dhar Chowdhury; Kunissery A Balasubramanian; Inian Samarasam
Journal:  Indian J Surg Oncol       Date:  2021-04-05

10.  Screening and risk factors of exocrine pancreatic insufficiency in critically ill adult patients receiving enteral nutrition.

Authors:  Sheng Wang; Lijie Ma; Yugang Zhuang; Bojie Jiang; Xiangyu Zhang
Journal:  Crit Care       Date:  2013-08-07       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.